Banner
HomeBest Practices → Nearly 1 in 3 Recent FDA Drug Approvals Followed By Major Safety Actions

Nearly 1 in 3 Recent FDA Drug Approvals Followed By Major Safety Actions Print E-mail
Written by Sydney Lupkin | KHN   
Tuesday, 16 May 2017 15:53

The Food and Drug Administration is under pressure from the Trump administration to approve drugs faster, but researchers at the Yale School of Medicine found that nearly a third of those approved from 2001 through 2010 had major safety issues years after they were widely available to patients.
 
Seventy-one of the 222 drugs approved in the first decade of the millennium were withdrawn, required a "black box" warning on side effects or warranted a safety announcement about new risks to the public, Yale professor Dr. Joseph Ross and his colleagues reported in JAMA on Tuesday <5.9.17>. The study included safety actions through Feb. 28.

Read More

Last Updated on Monday, 05 June 2017 13:28
 


Banner
Website design, development, and hosting provided by
Netphiles